Next Article in Journal
Mutation Distribution in the NSP4 Protein in Rotaviruses Isolated from Mexican Children with Moderate to Severe Gastroenteritis
Next Article in Special Issue
RSV Fusion: Time for a New Model
Previous Article in Journal
Localization, Concentration, and Transmission Efficiency of Banana bunchy top virus in Four Asexual Lineages of Pentalonia aphids
Previous Article in Special Issue
Respiratory Syncytial Virus: Current Progress in Vaccine Development
Viruses 2013, 5(3), 777-791; doi:10.3390/v5030777

Th17 Lymphocytes in Respiratory Syncytial Virus Infection

1,* , 2
1 Bone and Joint Research Unit, William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK 2 Department of Rheumatology, The Royal London Hospital, Mile End, Barts and The London, Queen Mary University of London, London, EC1M 6BQ, UK
* Author to whom correspondence should be addressed.
Received: 23 January 2013 / Revised: 22 February 2013 / Accepted: 25 February 2013 / Published: 5 March 2013
(This article belongs to the Special Issue Pneumoviruses and Metapneumoviruses)
View Full-Text   |   Download PDF [475 KB, 12 May 2015; original version 12 May 2015]   |   Browse Figure


Infection by respiratory syncytial virus (RSV) affects approximately 33 million infants annually worldwide and is a major cause of hospitalizations. Helper T lymphocytes (Th) play a central role in the immune response during such infections. However, Th lymphocytes that produce interleukin 17 (IL-17), known as Th17 lymphocytes, in addition to been protective can also cause pathology that accompany this type of infection. The protective effects of Th17 is associated with better prognosis in most infected individuals but heightened Th17 responses causes inflammation and pathology in others. Studies employing animal models haves shown that activated Th17 lymphocytes recruit neutrophils and facilitate tertiary lymphoid structure development in infected lungs. However, IL-17 also inhibits the ability of CD8+ lymphocytes to clear viral particles and acts synergistically with the innate immune system to exacerbate inflammation. Furthermore, IL-17 enhances IL-13 production which, in turn, promotes the activation of Th2 lymphocytes and excessive mucus production. Studies of these animal models have also shown that a lack of, or inadequate, responses by the Th1 subset of T lymphocytes enhances Th17-mediated responses and that this is detrimental during RSV co-infection in experimental asthma. The available evidence, therefore, indicates that Th17 can play contradictory roles during RSV infections. The factors that determine the shift in the balance between beneficial and adverse Th17 mediated effects during RSV infection remains to be determined.
Keywords: RSV; pneumovirus; mucus; interleukin 17; interleukin 23; interleukin 13; Th17 RSV; pneumovirus; mucus; interleukin 17; interleukin 23; interleukin 13; Th17
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Bystrom, J.; Al-Adhoubi, N.; Al-Bogami, M.; Jawad, A.S.; Mageed, R.A. Th17 Lymphocytes in Respiratory Syncytial Virus Infection. Viruses 2013, 5, 777-791.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert